Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
about
Applications of metabolomics in cancer researchRole of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-AnalysisWaterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviorsPlasma free amino acid profiling of five types of cancer patients and its application for early detectionGlobally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad CoverageCombining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.A novel serum metabolomics-based diagnostic approach for colorectal cancerMass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer.The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics.The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer.Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis.Serum amino acid profiles and their alterations in colorectal cancer.Metabonomics identifies serum metabolite markers of colorectal cancer.Estimation of psychological stress in humans: a combination of theory and practiceA combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolismA metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes.Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects.Plasma metabolite biomarkers for the detection of pancreatic cancerSerum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas.Determination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratificationMetabolomics and partial least square discriminant analysis to predict history of myocardial infarction of self-claimed healthy subjects: validity and feasibility for clinical practice.Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico.Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study.Bladder cancer determination via two urinary metabolites: a biomarker pattern approachEPMA position paper in cancer: current overview and future perspectives.Towards microbial fermentation metabolites as markers for health benefits of prebiotics.Urinary metabolite markers of precocious pubertyIsotopic Ratio Outlier Analysis of the S. cerevisiae Metabolome Using Accurate Mass Gas Chromatography/Time-of-Flight Mass Spectrometry: A New Method for Discovery.Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients.
P2860
Q24600728-500590D2-850B-4A03-995F-1D0446A8C56CQ28067664-E66ED9C5-FE60-4522-882C-10373FAC4B38Q28396163-A17D5E76-DB88-43B4-BE3E-3A4B6D6A5145Q28740654-E8C4056D-DCC1-484A-934C-BBDCF71BCC97Q33707386-2DABB417-28E3-4E86-88CF-B477FA5E968BQ33745104-D76926DB-3AAC-482B-A238-462C92CEC6DBQ33777586-F4DEB45B-8A6B-4C60-8433-17742D6F918EQ33877598-8DA9A16A-2F0C-4581-92F5-60E3117D3D15Q33888328-ABC39DF8-D72F-4210-9D21-1541E2AD9B53Q33966180-8F85C0B7-BA83-4AA1-B6F5-4F6EC522374BQ34063270-BCA6D370-5B26-4588-B578-14BB5DBFA620Q34145916-82710D6E-DCF3-4B43-9EE6-4633E415D7E6Q34170564-95072EC6-691D-4909-8784-9D9F12334FAAQ34336333-D233C5CB-E5A3-4DB0-8479-B7D6EAEAAEE9Q34339067-FCA19658-3C49-4FF4-A56A-AF7B7425C62CQ34347646-531B9D43-77D3-4110-83AA-6BE02BF08C10Q34424468-E9EE921A-AD9D-4D73-AF69-6B5939AAD2F5Q34587180-4BE33A82-3643-4525-8980-E84240DD3A9AQ34591157-8D037C96-D52A-4456-ABE8-ED408298ED3DQ34640062-5B4EC32B-3A3A-4CCE-8E90-E2223614EC62Q34660782-E2A32CD6-7E96-406E-A58E-17EEB086C152Q34723672-0453F3B9-875E-43DC-9856-9D8151DA3B5CQ34729993-E9927F27-C43C-4FAF-AE63-777E1B937CF4Q35006537-3A113DA8-B7ED-4E0A-82A1-F4B459EDB41EQ35034063-2764DFCF-7683-47AD-BC63-9DE55D605369Q35041720-553F1D5B-3006-4222-9DAC-5869E03DFAB3Q35072866-E861C05B-6CAF-45A6-8F38-D1B419622B85Q35098539-81ACB8D3-A159-498E-99F1-2F0D4FBF619CQ35112364-B34AE909-1764-4DC8-976F-64BABFC9106CQ35132600-77631920-6693-4310-83C1-D0CCA919FF15Q35211633-3ECEB2FB-568F-4FD3-982A-7E8EC052C7D8Q35214598-CE78118B-6E65-4A25-8F41-C2063A3B6299Q35346739-BE34D87E-F588-440C-AF8B-CBE932E19F3CQ35497484-D1E3F7ED-8107-4884-96E7-410F596A7C10Q35532215-6D4DAAC5-B745-4F62-9DC9-3516B15C46F5Q35686508-6D361481-4344-48A9-8FF6-1ABB00A7111FQ35722258-87E74976-BF90-463C-9EA5-B5B1335B11B1Q35906943-A4CBA0A2-AA0C-40D6-B65E-25FF1882E69FQ35914614-18308DD0-1110-4705-8139-FCEA073B1496Q35925208-F075299C-2E5B-4789-BF17-33F3AB4D77B7
P2860
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@en
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@nl
type
label
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@en
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@nl
prefLabel
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@en
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
@nl
P2093
P50
P356
P1476
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS
@en
P2093
Aihua Zhao
Guoxiang Cai
Sanjun Cai
Tianlu Chen
Xiaojiao Zheng
P304
P356
10.1021/PR9004162
P577
2009-10-01T00:00:00Z